Compare Aevo (AEVO) vs Mitosis (MITO) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Aevo vs Mitosis — how do they compare? Aevo trades at Rp327.38 (market cap Rp300,53M, Rp54,09M 24h volume), while Mitosis trades at Rp362.19 (market cap Rp65,88M, Rp94,65M 24h volume). The key difference: Aevo is far larger — about 4.6× Mitosis's market cap, and Aevo's circulating supply is 917,2M / 1B AEVO (92%) versus 181,3M / 1B MITO (19%) for Mitosis. Which is the better fit depends on your goals — on Pluang, investors hold Aevo for 87 Days and Mitosis for 19 Days on average.
| AEVO | MITO | |
|---|---|---|
Market Cap | Rp300,53M | Rp65,88M |
Volume (24h) | Rp54,09M | Rp94,65M |
Circulating Supply | 917,2M / 1B AEVO (92%) | 181,3M / 1B MITO (19%) |
Typical Hold Time | 87 Days | 19 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aevo is currently trading at Rp326.46 with a market cap of Rp301.12 million, showing a bearish technical signal as moving averages indicate selling pressure. The token trades near key support at Rp325, with neutral oscillators suggesting consolidation. No major protocol updates or ecosystem developments were noted recently, keeping fundamental drivers subdued.
Overall outlook remains cautious due to bearish technicals and low liquidity. Key opportunities include potential rebounds from support levels, while risks involve high volatility and limited market depth. Investors should monitor trading volume and on-chain activity for signs of momentum shifts.
Mitosis (MITO) is trading at Rp393.33 with a market cap of Rp71.86 million, showing a bearish technical outlook as moving averages signal strong selling pressure while oscillators remain neutral. The token's low circulating supply of 181,300 out of 1 million tokens and short average hold time of 19 days suggest high volatility. Recent news highlights a strategic acquisition involving MITO Material Solutions, though this pertains to a corporate entity and not the cryptocurrency's ecosystem.
Overall outlook is cautious due to bearish technical signals and limited liquidity. Key opportunities include potential price rebounds from oversold RSI levels, but major risks involve low market cap volatility, minimal exchange presence, and lack of clear token utility updates. Investors should monitor for genuine protocol developments rather than unrelated corporate news.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Aevo
Aevo is the world's first high-performance decentralized options exchange. The exchange runs on a custom EVM roll-up that rolls up to Ethereum. Aevo operates an off-chain orderbook with on-chain settlements. This means that once orders are matched, trades get executed and settled with smart contracts.
Read more on AEVO →About Mitosis
Mitosis is a cross-chain DeFi protocol that converts liquidity positions into programmable and composable assets. It tackles two significant inefficiencies in decentralized finance: the illiquidity of staked assets and limited access to high-yield opportunities for smaller users.
Read more on MITO →
